Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Karanes, C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 63 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chandrasekar, PH; Abraham, OC; Klein, J; Alangaden, G; Chalasani, G; Cassells, L; Dansey, R; Abella, S; Karanes, C; Peters, W; Baynes, R
      Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer

      CLINICAL INFECTIOUS DISEASES
    2. Dorr, R; Karanes, C; Spier, C; Grogan, T; Greer, J; Moore, J; Weinberger, B; Schiller, G; Pearce, T; Litchman, M; Dalton, W; Roe, D; List, AF
      Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    3. Sievers, EL; Larson, RA; Stadtmauer, EA; Estey, E; Lowenberg, B; Dombret, H; Karanes, C; Theobald, M; Bennett, JM; Sherman, ML; Berger, MS; Eten, CB; Loken, MR; van Dongen, JJM; Bernstein, ID; Appelbaum, FR
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

      JOURNAL OF CLINICAL ONCOLOGY
    4. List, AF; Kopecky, KJ; Willman, CL; Head, DR; Persons, DL; Slovak, ML; Dorr, R; Karanes, C; Hynes, HE; Doroshow, JH; Shurafa, M; Appelbaum, FR
      Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

      BLOOD
    5. Negrin, RS; Atkinson, K; Leemhuis, T; Hanania, E; Juttner, C; Tierney, K; Hu, WW; Johnston, LJ; Shizuru, JA; Stockerl-Goldstein, KE; Blume, KG; Weissman, IL; Bower, S; Baynes, R; Dansey, R; Karanes, C; Peters, W; Klein, J
      Transplantation of highly purified CD34(+)Thy-I+ hematopoietic stem cells in patients with metastatic breast cancer

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    6. Peters, WP; Baynes, RB; Cassells, L; Dansey, R; Klein, J; Hamm, C; Karanes, C; Abella, S
      The Dix/Geller article reviewed

      ONCOLOGY-NEW YORK
    7. Rimsza, LM; Kopecky, KJ; Ruschulte, J; Chen, IM; Slovak, ML; Karanes, C; Godwin, J; List, A; Willman, CL
      Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature

      LEUKEMIA
    8. Baynes, RD; Dansey, RD; Klein, JL; Karanes, C; Cassells, L; Abella, E; Wei, WZ; Galy, A; Du, W; Wood, G; Peters, WP
      High-dose chemotherapy and autologous stem cell transplantation for breastcancer

      CANCER INVESTIGATION
    9. List, AF; Maziarz, R; Stiff, P; Jansen, J; Liesveld, J; Andrews, F; Schuster, M; Wolff, S; Litzow, M; Karanes, C; Dahlberg, S; Kirkhart, B; Bianco, JA; Singer, JW
      A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients

      BONE MARROW TRANSPLANTATION
    10. Klein, JL; Rey, PM; Dansey, RD; Karanes, C; Du, W; Abella, E; Cassells, L; Hamm, C; Peters, WP; Baynes, RD
      Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer

      BONE MARROW TRANSPLANTATION
    11. Rosen, PJ; Rankin, C; Head, DR; Boldt, DH; Luthardt, FW; Norwood, T; Pugh, RP; Karanes, C; Appelbaum, FR
      A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia

      LEUKEMIA RESEARCH
    12. Baynes, RD; Hamm, C; Dansey, R; Klein, J; Cassells, L; Karanes, C; Abella, E; Peters, WP
      Bone marrow and peripheral blood hematopoietic stem cell transplantation: Focus on autografting

      CLINICAL CHEMISTRY
    13. Chen, C; Lin, H; Karanes, C; Pettit, GR; Chen, BD
      Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis

      CANCER RESEARCH
    14. Nash, RA; Antin, JH; Karanes, C; Fay, JW; Avalos, BR; Yeager, AM; Przepiorka, D; Davies, S; Petersen, FB; Bartels, P; Buell, D; Fitzsimmons, W; Anasetti, C; Storb, R; Ratanatharathorn, V
      Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

      BLOOD
    15. Aref, A; Narayan, S; Tekyi-Mensah, S; Varterasian, M; Dan, M; Eilender, D; Karanes, C; Al-Katib, A
      Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma

      RADIATION ONCOLOGY INVESTIGATIONS
    16. Klein, JL; Rey, PM; Dansey, R; Karanes, C; Abella, E; Cassells, L; Hamm, C; Flowers, M; Couwlier, C; Peters, WP; Baynes, RD
      Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells

      BONE MARROW TRANSPLANTATION
    17. Karanes, C; Kopecky, KJ; Head, DR; Grever, MR; Hynes, HE; Kraut, EH; Vial, RH; Lichtin, A; Nand, S; Samlowski, WE; Appelbaum, FR
      A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia

      LEUKEMIA RESEARCH
    18. DU W; DANSEY R; ABELLA EM; BAYNES R; PETERS WP; KLEIN J; AKHTAR A; CHEREDNIKOVA L; KARANES C
      SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN SELECTED PATIENTS OVER 50 YEARS OF AGE - A SINGLE INSTITUTIONS EXPERIENCE

      Bone marrow transplantation
    19. RATANATHARATHORN V; NASH RA; PRZEPIORKA D; DEVINE SM; KLEIN JL; WEISDORF D; FAY JW; NADEMANEE A; ANTIN JH; CHRISTIANSEN NP; VANDERJAGT R; HERZIG RH; LITZOW MR; WOLFF SN; LONGO WL; PETERSEN FB; KARANES C; AVALOS B; STORB R; BUELL DN; MAHER RM; FITZSIMMONS WE; WINGARD JR
      PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION

      Blood
    20. SAVASAN S; ABELLA E; KARANES C; RAVINDRANATH Y
      RECURRENT BREAST RELAPSES IN A PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Acta haematologica
    21. VARTERASIAN M; ZALUPSKI M; KARANES C
      THE HETEROGENEITY OF LEUKEMIA OCCURRING AFTER TREATMENT FOR SARCOMA

      American journal of clinical oncology
    22. VARTERASIAN M; JANAKIRAMAN N; KARANES C; ABELLA E; UBERTI J; DRAGOVIC J; RAMAN SBK; ALKATIB A; DU W; SILVER SM; ADAMS PT; SENSENBRENNER L; RATANATHARATHORN V
      TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA - A MULTICENTER COMPARATIVE-ANALYSIS OF PERIPHERAL-BLOOD STEM-CELL AND ALLOGENEIC TRANSPLANT

      American journal of clinical oncology
    23. VARTERASIAN ML; AREF A; KARANES C
      A BLOOD STEM-CELL TRANSPLANT IN A PERSON WITH CONCOMITANT HODGKIN-DISEASE AND TESTICULAR-CARCINOMA

      Bone marrow transplantation
    24. CHANDRASEKAR PH; MOMIN F; KARANES C; ABELLA S; RATANATHARATHORN V; SENSENBRENNER L
      DISSEMINATED TOXOPLASMOSIS IN MARROW RECIPIENTS - A REPORT OF 3 CASESAND A REVIEW OF THE LITERATURE

      Bone marrow transplantation
    25. KLEIN JL; DANSEY RD; KARANES C; AKTAR A; ABELLA S; CASSELLS L; BAYNES R; PETERS PW
      CD34 SELECTED PBPC TRANSPLANT FOR METASTATIC BREAST - MOBILIZATION, TRANSPLANTATION, ENGRAFTMENT AND SAFETY

      Blood
    26. DANSEY R; KLEIN J; KARANES C; AKHTAR A; CASSELLS L; PETERS WP; BAYNES RD
      SUCCESSFUL PERIPHERAL-BLOOD MOBILIZATION OF CD34 PROGENITOR CELLS BY CYCLOPHOSPHAMIDE, PACLITAXEL AND G-CSF AFTER FAILURE WITH G-CSF ALONE

      Blood
    27. DAVIES SM; HARRIS RE; VANWEELSIPMAN MH; DOKAL I; SKINNER R; CASPER JT; KURTZBERG J; SMITH F; KARANES C; CHEN A; CAIRO M; YEAGER AM; DEFOR T; WAGNER JE
      UNRELATED DONOR STEM-CELL TRANSPLANT FOR FANCONI-ANEMIA - MULTICENTERREPORT OF 49 CASES

      Blood
    28. SMITH MR; VARTERASIAN M; KARANES C; PEMBERTON P; YESLOW G; HALBHERR T; SCHILDER RJ; MILLENSON MM; ALKATIB AM
      PHASE-II TRIAL OF PEND CHEMOTHERAPY IN RELAPSED OR REFRACTORY HODGKINS-DISEASE

      Blood
    29. DU W; DANSEY R; ABELLA EM; BAYNES R; PETERS WP; KLEIN J; AKHTAR A; CHEREDNIKOVA L; KARANES C
      SUCCESSFUL ALLOGENEIC BONE-MARROW TRANSPLANTATION IN SELECTED PATIENTS OVER 50 YEARS OF AGE - A SINGLE INSTITUTION EXPERIENCE

      Blood
    30. NASH RA; ANTIN J; KARANES C; FAY J; AVALOS B; YEAGER AM; PRZEPIORKA D; DAVIES S; PETERSEN F; BUELL D; FITZSIMMONS W; BARTELS P; HANSEN J; ANASETTI C; STORB R; RATANATHARATHORN V
      PHASE-III STUDY COMPARING TACROLIMUS (FK506) WITH CYCLOSPORINE (CSP) FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROWTRANSPLANTATION FROM UNRELATED DONORS

      Blood
    31. GREENBERG P; ADVANI R; KEATING A; GULATI SC; NIMER S; CHAMPLIN R; KARANES C; GORIN NC; POWLES RL; SMITH A; LAMBORN K; CUFFIE C
      GM-CSF ACCELERATES NEUTROPHIL RECOVERY AFTER AUTOLOGOUS HEMATOPOIETICSTEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    32. LIST AF; KARANES C; DORR R; SPIER C; GROGAN T; GREER J; MOORE J; WEINBERGER J; SCHILLER G; DALTON W; PEARCE T; LITCHMAN M
      MODULATION OF ANTHRACYCLINE RESISTANCE IN POOR-RISK ACUTE MYELOID-LEUKEMIA (AML) WITH SDZ PSC-833 - RESULTS OF A PHASE I II MULTICENTER STUDY/

      Blood
    33. RATANATHARATHORN V; NASH RA; DEVINE SM; PRZEPIORKA D; KLEIN JL; WEISDORF DJ; FAY JW; NADEMANEE AP; ANTIN JH; KARANES C; AVALOS BR; CHRISTIANSEN NP; VANDERJAGT RH; HERZIG RH; LITZOW MR; WOLFF SN; LONGO WR; PETERSEN FB; BUELL DN; MAHER RM; FITZSIMMONS WE; WINGARD JR
      PHASE-III STUDY COMPARING TACROLIMUS (PROGRAF(R), FK506) WITH CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    34. MOHAMED AN; KOPPITCH F; VARTERASIAN M; KARANES C; YAO KL; SARKAR FH
      BCR ABL FUSION LOCATED ON CHROMOSOME-9 IN CHRONIC MYELOID-LEUKEMIA WITH A MASKED PH CHROMOSOME/

      Genes, chromosomes & cancer
    35. VARTERASIAN M; RATANATHARATHORN V; UBERTI JP; KARANES C; ABELLA E; MOMIN F; KASTENSPORTES C; ALKATIB A; LUM L; HEILBRUN LK; SENSENBRENNER LL
      CLINICAL COURSE AND OUTCOME OF PATIENTS WITH HODGKINS-DISEASE WHO PROGRESS AFTER AUTOLOGOUS TRANSPLANTATION

      Leukemia & lymphoma
    36. CHEN B; LI Y; SHEN BF; KARANES C; SENSENBRENNER L
      THE BETA-SUBUNIT OF THE GM-CSF RECEPTOR IS PHYSICALLY ASSOCIATED WITHLYN-PROTEIN TYROSINE KINASE (P53 56(LYN)) IN M-07E HUMAN LEUKEMIA-CELLS/

      Experimental hematology
    37. SHEARER C; CHANDRASEKAR PH; SENSENBRENNER L; RATANATHARATHORN V; KARANES C; MOMIN F; ABELLA S; LUM L; UBERTI J
      PULMONARY NOCARDIOSIS IN A PATIENT WITH A BONE-MARROW TRANSPLANT

      Bone marrow transplantation
    38. VARTERASIAN M; RATANATHARATHORN V; KARANES C; UBERTI J; MOMIN F; ABELLA E; LUM LG; HEILBRUN LK; SENSENBRENNER LL
      BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - THE WAYNE-STATE EXPERIENCE

      Bone marrow transplantation
    39. SHIBUYA TY; MOMIN F; ABELLA E; JACOBS JR; KARANES C; RATANATHARATHORN V; SENSENBRENNER LL; LUM LG
      SINUS DISEASE IN THE BONE-MARROW TRANSPLANT POPULATION - INCIDENCE, RISK-FACTORS, AND COMPLICATIONS

      Otolaryngology and head and neck surgery
    40. TURKERI LN; LUM LG; UBERTI JP; ABELLA E; MOMIN F; KARANES C; SENSENBRENNER LL; HAAS GP
      PREVENTION OF HEMORRHAGIC CYSTITIS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT PREPARATIVE REGIMENS WITH CYCLOPHOSPHAMIDE AND BUSULFAN - ROLE OF CONTINUOUS BLADDER IRRIGATION

      The Journal of urology
    41. LI Y; SHEN BF; KARANES C; SENSENBRENNER L; CHEN B
      ASSOCIATION BETWEEN LYN PROTEIN-TYROSINE KINASE (P53 56(LYN)) AND THEBETA-SUBUNIT OF THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) RECEPTORS IN A GM-CSF-DEPENDENT HUMAN MEGAKARYOCYTIC LEUKEMIA-CELL LINE (M-07E)/

      The Journal of immunology
    42. CHEREDNIKOVA L; KARANES C; ABUBAKR Y; KLEIN J; ABELLA E
      ALLOGENIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) IN PATIENTS OLDER THAN 50 YEARS OF AGE - A SINGLE-CENTER EXPERIENCE

      Blood
    43. ABELLA E; KARANES C; INOUE S; RAVINDRANATH Y
      LONG-TERM FOLLOW-UP OF CHILDREN WITH SEVERE APLASTIC-ANEMIA (SAA) TREATED WITH ANTITHYMOCYTE GLOBULIN (ATG) AT A SINGLE INSTITUTION

      Blood
    44. KATATO K; ABELLA E; DU W; ABUBAKR Y; KARANES C
      MATCHED SIBLING DONOR (MSD) AND MATCHED UNRELATED DONOR (MUD) RECIPIENTS OF ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOCYTIC-LEUKEMIA (CML)

      Blood
    45. SCHULTZ KR; FERNANDEZ CV; ISRAEL DM; MAGEE F; WENSLEY D; SARGENT MA; ABELLA E; KARANES C
      ASSOCIATION OF GASTROESOPHAGEAL REFLUX WITH OBSTRUCTIVE LUNG-DISEASE IN CHILDREN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    46. UBERTI JP; RATANATHARATHORN V; KARANES C; SENSENBRENNER LL
      ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Leukemia & lymphoma
    47. CHANDRASEKAR PH; GATNY CM; SENSENBRENNER L; RATANATHARATHORN V; LUM L; KARANES C; UBERTI J; DEPLANQUE M; SCHULTZ K
      THE EFFECT OF FLUCONAZOLE PROPHYLAXIS ON FUNGAL COLONIZATION IN NEUTROPENIC CANCER-PATIENTS

      Journal of antimicrobial chemotherapy
    48. LUM L; BITONTI O; JIN NR; GALOFORO S; WALKER A; LUM C; ABELLA E; BABINGTON R; KARANES C; MOMIN F; UBERTI J; RATANATHARATHORN V; SENSENBRENNER L
      INTRAVENOUS GAMMA-GLOBULIN (IVIG) DOES NOT ALTER IMMUNE PARAMETERS INA RANDOMIZED TRIAL AFTER BONE-MARROW TRANSPLANTATION (BMT)

      Experimental hematology
    49. MOMIN F; RATNATHARATHORN V; UBERTI J; ABELLA E; KARANES C; CASE P; LUM L; SENSENBRENNER L
      COMPARISON OF OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)USING HLA IDENTICAL SIBLING, MATCHED UNRELATED, AND RELATED HLA MISMATCHED DONORS

      Experimental hematology
    50. ALANGADEN G; CHANDRASEKAR PH; BAILEY E; KHALIQ Y; SENSENBRENNER L; RATANATHARATHORN V; KARANES C; DEPLANQUE M; UBERTI J; LUM L
      ANTIFUNGAL PROPHYLAXIS WITH LOW-DOSE FLUCONAZOLE DURING BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    51. SCHULTZ KR; RATANATHARATHORN V; ABELLA E; EISENBREY AB; KARANES C; LUM LG; DEPLANQUE MM; UBERTI JP; RAVINDRANATH Y; SENSENBRENNER LL
      GRAFT FAILURE IN CHILDREN RECEIVING HLA-MISMATCHED MARROW TRANSPLANTSWITH BUSULFAN-CONTAINING REGIMENS

      Bone marrow transplantation
    52. RATANATHARATHORN V; UBERTI J; KARANES C; LUM LG; ABELLA E; DAN ME; HUSSEIN M; SENSENBRENNER LL
      PHASE-I STUDY OF ALPHA-INTERFERON AUGMENTATION OF CYCLOSPORINE-INDUCED GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    53. LUM LG; JOSHI ID; SMITH MR; RATANATHARATHORN V; GALOFORO SC; KARANES C; UBERTI JP; SENSENBRENNER LL
      CONSTITUTIVE AND MITOGEN-STIMULATED CYTOKINE MESSENGER-RNA EXPRESSIONBY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM MOST AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS IS INTACT

      Bone marrow transplantation
    54. BAZARBASHI MS; SHURAFA MS; KARANES C
      TREATMENT OF CYCLOPHOSPHAMIDE-INDUCED INTRACTABLE HEMORRHAGIC CYSTITIS

      Annals of saudi medicine
    55. SMITH MR; KHANUJA PS; ALKATIB A; BISHOP CR; ANDERSEN J; HUSSEIN ME; KARANES C
      CONTINUOUS-INFUSION ABDIC THERAPY FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE

      Cancer
    56. RATANATHARATHORN V; UBERTI J; KARANES C; ABELLA E; LUM LG; MOMIN F; CUMMINGS G; SENSENBRENNER LL
      PROSPECTIVE COMPARATIVE TRIAL OF AUTOLOGOUS VERSUS ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA

      Blood
    57. RATANATHARATHORN V; KARANES C; MOMIN F; UBERTI JP; SENSENBRENNER LL; ABELLA E; LUM LG
      PREPARATIVE REGIMES WITHOUT TOTAL-BODY IRRADIATION (TBI) IN THE RECIPIENTS OF UNRELATED DONOR MARROW

      Blood
    58. RATANATHARATHORN V; KARANES C; UBERTI J; ABELLA E; LUM L; SENSENBRENNER L
      PROSPECTIVE COMPARATIVE TRIAL OF ALLOGENEIC VS AUTOLOGOUS BONE-MARROWTRANSPLANTATION IN PATIENTS WITH NON-HODGKINS-LYMPHOMA

      Experimental hematology
    59. RATANATHARATHORN V; UBERTI JP; KARANES C; LUM LG; ABELLA E; SENSENBRENNER LL
      BUSULFAN, ARA-C AND CYCLOPHOSPHAMIDE (BAC) AS PREPARATIVE REGIMEN FORALLOGENIC TRANSPLANTS IN HIGH-RISK MYELOID DISORDERS

      Experimental hematology
    60. LUM LG; JOSHI ID; GALOFORO SC; ABELLA E; KARANES C; RATANATHARATHORN V; SCHULTZ KR; UBERTI JP; SENSENBRENNER LL; LEDBETTER JA; JUNE CH
      COACTIVATION WITH ANTI-CD28 MONOCLONAL-ANTIBODY ENHANCES ANTI-CD3 MONOCLONAL ANTIBODY-INDUCED PROLIFERATION AND IL-2 SYNTHESIS IN T-CELLS FROM AUTOLOGOUS BONE-MARROW TRANSPLANT RECIPIENTS

      Bone marrow transplantation
    61. KARANES C; UBERTI JP; RATANATHARATHORN V; LUM L; ABELLA E; MOMIN F; SENSENBRENNER L
      CYCLOPHOSPHAMIDE, VP-16, AND BCNU (CVB) FOR AUTOLOGOUS AND ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) IN NON-HODGKINS-LYMPHOMA (NHL)

      Blood
    62. UBERTI JP; KARANES C; RATANATHARATHORN V; LUM L; ABELLA E; MOMIN F; SENSENBRENNER L
      BUSULFAN-BASED PREPARATIVE REGIMENS FOR ACUTE MYELOID-LEUKEMIA IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - THE ROLE OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) FOR HIGH-RISK PATIENTS

      Blood
    63. RATANATHARATHORN V; KARANES C; UBERTI J; LUM LG; DEPLANQUE MM; SCHULTZ KR; CRONIN S; DAN ME; MOHAMED A; HUSSEIN M; SENSENBRENNER LL
      BUSULFAN-BASED REGIMENS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION INPATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 09:24:22